Total Payments
$1,190
2024 Payments
$142.09
Companies
9
Transactions
36
Medicare Patients
1,778
Medicare Billing
$396,182
Payment Breakdown by Category
Food & Beverage$628.89 (52.9%)
Education$560.62 (47.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $628.89 | 27 | 52.9% |
| Education | $560.62 | 9 | 47.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $277.07 | 8 | $0 (2019) |
| Janssen Products, LP | $216.48 | 3 | $0 (2022) |
| Gilead Sciences, Inc. | $198.15 | 9 | $0 (2022) |
| Shionogi Inc | $154.08 | 4 | $0 (2024) |
| ViiV Healthcare Company | $107.82 | 7 | $0 (2020) |
| The Medicines Company | $104.74 | 1 | $0 (2017) |
| Insmed, Inc. | $74.99 | 1 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $28.48 | 1 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $27.70 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $142.09 | 3 | Shionogi Inc ($142.09) |
| 2022 | $110.67 | 3 | Janssen Products, LP ($85.00) |
| 2021 | $59.97 | 2 | Janssen Products, LP ($31.49) |
| 2020 | $11.40 | 1 | ViiV Healthcare Company ($11.40) |
| 2019 | $257.14 | 7 | Janssen Products, LP ($99.99) |
| 2018 | $239.89 | 12 | Gilead Sciences, Inc. ($184.47) |
| 2017 | $368.35 | 8 | Astellas Pharma US Inc ($207.21) |
All Payment Transactions
36 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/13/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $121.06 | General |
| Category: Infections and Infectious Diseases | ||||||
| 06/21/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $5.79 | General |
| Category: Infections and Infectious Diseases | ||||||
| 04/25/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Infections and Infectious Diseases | ||||||
| 08/26/2022 | Gilead Sciences, Inc. | Veklury (Drug) | Education | In-kind items and services | $13.68 | General |
| Category: COVID-19 | ||||||
| 04/07/2022 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $11.99 | General |
| Category: Infections and Infectious Diseases | ||||||
| 02/24/2022 | Janssen Products, LP | SYMTUZA (Drug) | Education | In-kind items and services | $85.00 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 11/03/2021 | Janssen Products, LP | SYMTUZA (Drug) | Education | In-kind items and services | $31.49 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 11/03/2021 | Janssen Pharmaceuticals, Inc | — | Education | In-kind items and services | $28.48 | General |
| 03/05/2020 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $11.40 | General |
| Category: HIV | ||||||
| 11/21/2019 | Janssen Products, LP | Symtuza (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 10/29/2019 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $12.12 | General |
| Category: HIV | ||||||
| 10/03/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $11.44 | General |
| 09/19/2019 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: HIV | ||||||
| 07/09/2019 | Insmed, Inc. | Arikayce (Drug) | Education | In-kind items and services | $74.99 | General |
| Category: Respiratory | ||||||
| 04/18/2019 | Merck Sharp & Dohme Corporation | ISENTRESS (Drug), PIFELTRO, DIFICID | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/16/2019 | Astellas Pharma US Inc | — | Education | In-kind items and services | $28.99 | General |
| 11/29/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.03 | General |
| 11/29/2018 | Astellas Pharma US Inc | CRESEMBA (Drug) | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/08/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $28.78 | General |
| 11/08/2018 | ViiV Healthcare Company | JULUCA (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: HIV | ||||||
| 10/18/2018 | Astellas Pharma US Inc | CRESEMBA (Drug) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 08/22/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.99 | General |
| 08/14/2018 | Astellas Pharma US Inc | CRESEMBA (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 07/24/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.73 | General |
| 06/19/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.76 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 430 | 1,366 | $333,130 | $106,749 |
| 2022 | 6 | 399 | 1,116 | $278,185 | $86,012 |
| 2021 | 6 | 390 | 1,158 | $289,040 | $92,077 |
| 2020 | 6 | 559 | 1,401 | $310,521 | $111,345 |
Total Patients
1,778
Total Services
5,041
Medicare Billing
$396,182
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 145 | 852 | $170,400 | $56,280 | 33.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 88 | 174 | $49,590 | $17,128 | 34.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 109 | 115 | $63,250 | $16,340 | 25.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 51 | 168 | $33,600 | $10,982 | 32.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 21 | 30 | $6,300 | $3,204 | 50.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 16 | 27 | $9,990 | $2,814 | 28.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 144 | 667 | $133,400 | $40,191 | 30.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 104 | 112 | $61,600 | $18,638 | 30.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 73 | 159 | $45,315 | $13,744 | 30.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 49 | 146 | $29,070 | $9,935 | 34.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 17 | 19 | $3,990 | $2,021 | 50.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 12 | 13 | $4,810 | $1,484 | 30.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 125 | 636 | $127,200 | $39,095 | 30.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 76 | 210 | $59,850 | $18,556 | 31.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 103 | 107 | $58,850 | $18,331 | 31.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 53 | 166 | $32,550 | $11,595 | 35.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 19 | 24 | $5,040 | $2,757 | 54.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 14 | 15 | $5,550 | $1,743 | 31.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 195 | 795 | $113,586 | $49,451 | 43.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 144 | 150 | $82,500 | $26,127 | 31.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 102 | 206 | $58,710 | $18,584 | 31.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 59 | 179 | $35,215 | $9,869 | 28.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 32 | 35 | $12,950 | $4,142 | 32.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 27 | 36 | $7,560 | $3,171 | 41.9% |
About John Mccarthy
John Mccarthy is a Infectious Disease healthcare provider based in Whittier, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1679650923.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, John Mccarthy has received a total of $1,190 in payments from pharmaceutical and medical device companies, with $142.09 received in 2024. These payments were reported across 36 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($628.89).
As a Medicare-enrolled provider, Mccarthy has provided services to 1,778 Medicare beneficiaries, totaling 5,041 services with total Medicare billing of $396,182. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Other Specialties Internal Medicine
- Location Whittier, CA
- Active Since 11/01/2006
- Last Updated 02/12/2021
- Taxonomy Code 207RI0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1679650923
Products in Payments
- Fetroja (Drug) $154.08
- SYMTUZA (Drug) $116.49
- ORBACTIV (Drug) $104.74
- Symtuza (Drug) $99.99
- Arikayce (Drug) $74.99
- TRIUMEQ (Drug) $56.40
- CRESEMBA (Drug) $40.87
- DOVATO (Drug) $36.87
- ISENTRESS (Drug) $16.26
- JULUCA (Drug) $14.55
- Veklury (Drug) $13.68
- Cresemba (Drug) $9.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.